| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 12/08/2009 | US7628849 Fluorinated bis-(phthalocyanylaluminoxy)silyl pigments |
| 12/08/2009 | CA2540858C Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication |
| 12/08/2009 | CA2422354C Pyrazole compounds useful as protein kinase inhibitors |
| 12/08/2009 | CA2361525C Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands |
| 12/08/2009 | CA2314613C Azolo triazines and pyrimidines |
| 12/03/2009 | WO2009146358A1 Imidazopyridine and related analogs as sirtuin modulators |
| 12/03/2009 | WO2009145360A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor |
| 12/03/2009 | WO2009145320A1 Process for producing hydroxyalkyltriethylenediamine compound, and catalyst composition for the production of polyurethane resin using the hydroxyalkyltriethylenediamine compound |
| 12/03/2009 | WO2009145289A1 Inhibitor of analgesic tolerance |
| 12/03/2009 | WO2009144548A1 Imidazo [2,1-b] purine derivatives as trpa1 modulators |
| 12/03/2009 | WO2009144494A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states |
| 12/03/2009 | WO2009143684A1 Processes for preparing pemetrexed disodium and its intermediate,4-(4-carbomethoxyphenyl)butanal |
| 12/03/2009 | WO2009099596A3 Macrocyclic serine protease inhibitors |
| 12/03/2009 | WO2009091856A3 Beta-lactamase inhibitors |
| 12/03/2009 | WO2009077741A3 3-substituted-4-0x0-3, 4-dihydro-imidazo- [5, 1-d] [1,2,3,5] -tetrazine-8-carboxylic acid amides as anticancer agents |
| 12/03/2009 | WO2009063504A3 Novel crystal modification of epinastine or salts thereof and process for preparation thereof |
| 12/03/2009 | US20090299070 Organic Semiconductors and Their Manufacture |
| 12/03/2009 | US20090299060 Compounds and methods for inhibiting mitotic progression |
| 12/03/2009 | US20090299057 Meropenem intermediate in novel crystalline form and a method of manufacture of meropenem |
| 12/03/2009 | US20090298858 Potent parp inhibitors |
| 12/03/2009 | US20090298841 serotonin receptor modulators such as 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline, used for treating obesity, nervous system disorders such as dementia, schizophrenia and Alzheimer's disease, and as cognition activators |
| 12/03/2009 | US20090298837 poly(ADP-ribose) polymerase (PARP) inhibitors such as 9-[(Hydrozinooxy)carbonyl]-2,7-dihydro-6-methoxy 3H-pyrido-[4,3,2-de]phthalazin-3-one, used for treating neuron tissue damage resulting from ischemia and reperfusion injury, depression, inflammatory bowel disorders, arthritis, gout, pain and sepsis |
| 12/03/2009 | US20090298824 Organic compounds |
| 12/03/2009 | US20090298823 Inhibitors of protein kinases |
| 12/03/2009 | US20090298810 IL-8 Receptor Antagonists |
| 12/03/2009 | US20090298809 5-ht3 receptor modulators, methods of making, and use thereof |
| 12/03/2009 | US20090293764 Dye compound and ink containing dye compound |
| 12/03/2009 | CA2726262A1 Imidazopyridine and related analogs as sirtuin modulators |
| 12/03/2009 | CA2726202A1 Process for producing hydroxyalkyltriethylenediamine, and catalyst composition for the production of polyurethane resin using it |
| 12/03/2009 | CA2726198A1 Inhibitor of analgesic tolerance |
| 12/03/2009 | CA2725110A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor |
| 12/03/2009 | CA2721065A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states |
| 12/02/2009 | EP2128138A1 Pyrazole compound |
| 12/02/2009 | EP2125818A1 New classical antifolates |
| 12/02/2009 | EP2125817A1 7-(3',4'-dialkoxyphenyl)-[1,2,4]-triazolo[1,5-a]pyrimidine compounds, process for preparing thereof, and pharmaceutical composition for treating or preventing asthma, chronic obstructive pulmonary disease, arthritis, atopic dermatitis, tumor and degenerative brain diseases comprising the same |
| 12/02/2009 | EP2125816A2 Metalloprotease inhibitors containing a heterocyclic moiety |
| 12/02/2009 | EP2125738A1 Immune response modifier compositions and methods |
| 12/02/2009 | EP2124560A1 2-aminopyrimidine modulators of the histamine h4 receptor |
| 12/02/2009 | EP1740673B1 Triazole derivatives and use therof in organic light-emitting diodes(oleds) |
| 12/02/2009 | CN101595110A 7-substituted purine derivatives for immunosuppression |
| 12/02/2009 | CN101591341A Alkyl porphyrin compound, preparation and application thereof in field of medicaments and pesticides |
| 12/02/2009 | CN101591340A 5,10,15,20-tetra-(5-drewamine amyl)-chlorin, preparation and application thereof in field of medicaments and pesticides |
| 12/02/2009 | CN101591339A Method for preparing sodium copper chlorophyllin by using watermelon outer peel |
| 12/02/2009 | CN101591338A Method for synthesizing indiplon |
| 12/02/2009 | CN101591295A Water-soluble benzopyrazolyl quaternary ammonium salt, preparation method thereof and application thereof |
| 12/02/2009 | CN101591281A Phosphonate compounds having immuno-modulatory activity |
| 12/02/2009 | CN101591084A Method for treating glyphosate waste water and reducing the emission of carbon dioxide |
| 12/02/2009 | CN100564381C N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 12/02/2009 | CN100564380C Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors |
| 12/02/2009 | CN100563653C Heterocyclic compounds which are active as inhibitors of beta lactamases |
| 12/01/2009 | US7626031 5-[(1-Ethylpiperidin-4-yl)amino]-3-[(3-fluorophenyl)(1H-imidazol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one; antiproliferative agents; modulating cell differentiation,migration, and chemoinvasion; endothelial growth factor-modulated diseases; antiarthritic agents; graft versus host diseases |
| 12/01/2009 | US7626026 Pyrrolo-indole and pyrrolo-quinoline derivatives as prodrugs for tumour treatment |
| 12/01/2009 | US7626021 morpholin-4-yl-{3-[3-(1H-pyrazol-4-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl-phenyl}-methanone; FMS-like tyrosine kinase 3 (FLT3), is implicated in cancers, including leukemia, such as acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and myelodysplasia |
| 12/01/2009 | US7625937 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators |
| 12/01/2009 | US7625922 Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds |
| 12/01/2009 | US7625913 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 12/01/2009 | US7625909 N-{3-[2-(2-Fluoro-4-methoxyphenyl)-ethyl]-4-oxo-3,4-dihydroquinazolin-7yl}-N-indan-2-yl-3,5-dimethylpiperazine-1-carboxamidine; melanocortin-4 receptor agonists; diabetes |
| 12/01/2009 | US7625907 administering a drug of 1,5-bis(3-nitrooxypropyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one, for heart failure and stable angina, cardiovascular disorders |
| 12/01/2009 | US7625906 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 12/01/2009 | US7625899 antiproliferative, antitumor and anticarcinogenic agent; cyclin dependent kinase inhibitor |
| 12/01/2009 | US7625894 Pyrrolo[2,3-d]Pyrimidines as Protein Tyrosine Kinase Inhibitors |
| 12/01/2009 | US7625888 {(1R)-1-(2,4,5-Trifluorobenzyl)-2-[9-(trifluoromethyl)-5,6-dihydrobis[1,2,4]triazolo[1,5-a:3',4'-c]pyrazin-3-yl]ethyl}amine, hydrochloride; metformin; treating non-insulin dependent (Type 2) diabetes in a mammal |
| 12/01/2009 | US7625841 invention also relates to the preparation of the compounds, to their use as herbicides and to herbicidal compositions comprising the novel compounds. |
| 11/26/2009 | WO2009143211A2 Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same |
| 11/26/2009 | WO2009143051A1 Substituted imidazopyr-and imidazotri-azines |
| 11/26/2009 | WO2009143039A2 Heterocyclic compounds as factor ixa inhibitors |
| 11/26/2009 | WO2009143024A2 Compounds and methods for kinase modulation, and indications therefor |
| 11/26/2009 | WO2009143018A2 Compounds and methods for kinase modulation, and indications therefor |
| 11/26/2009 | WO2009141288A2 Switchable special effect substances |
| 11/26/2009 | WO2009141238A1 Gpr119 receptor agonists |
| 11/26/2009 | WO2009112462A3 Novel 1,4-diaza-bicyclo[3.2.1]octane derivatives useful as nicotinic acetylcholine receptor modulators |
| 11/26/2009 | WO2009108551A3 Heteroaryl amide analogues |
| 11/26/2009 | WO2009076440A4 Fungicidal bicyclic pyrazoles |
| 11/26/2009 | US20090291996 Caspofungin free of caspofungin Co |
| 11/26/2009 | US20090291968 Substituted indazole derivatives, their manufacture and use as pharmaceutical agents |
| 11/26/2009 | US20090291957 Heterocyclic derivatives and their use as therapeutic agents |
| 11/26/2009 | US20090291956 SALTS OF 2-FLUORO-N-METHYL-4-[7-(QUINOLIN-6-YL-METHYL)-IMIDAZO[1,2-b][1,2,4]TRIAZIN-2-YL]BENZAMIDE AND PROCESSES RELATED TO PREPARING THE SAME |
| 11/26/2009 | US20090291948 Sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 11/26/2009 | US20090291941 Tyrosine Kinase Inhibitors |
| 11/26/2009 | US20090291938 Polo-like kinase inhibitors |
| 11/26/2009 | US20090291934 Method for decomposing an allergen |
| 11/26/2009 | CA2724842A1 Imidazo[1,2-a]pyridine compounds |
| 11/26/2009 | CA2724742A1 Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same |
| 11/26/2009 | CA2724430A1 Heterocyclic compounds as factor ixa inhibitors |
| 11/26/2009 | CA2724011A1 Gpr119 receptor agonists |
| 11/26/2009 | CA2720729A1 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 11/25/2009 | EP2123654A1 Pyrazolopyrimidine compound |
| 11/25/2009 | EP2123301A1 Therapeutic agent for urinary tract disease |
| 11/25/2009 | EP2121697A1 Compounds for the treatment of hepatitis c |
| 11/25/2009 | EP2121633A2 Piperazine derivatives for treatment of ad and related conditions |
| 11/25/2009 | EP2121630A1 Fast dissociating dopamine 2 receptor antagonists |
| 11/25/2009 | EP1848694B1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 11/25/2009 | EP1242385B1 Cytokine, especially tnf-alpha, inhibitors |
| 11/25/2009 | CN101589045A Imidazopyrazines as protein kinase inhibitors |
| 11/25/2009 | CN101585839A 6-methoxyl-3a-(trifluoromethyl)-2, 3, 3a,4-tetrahydro-1H-benzo[d]pyrrole[1,2-a] imidazole-1-one and synthesizing method thereof |
| 11/25/2009 | CN100562515C 2-halogen-6-alkyl-phenyl substituted tetramic acid derivatives |
| 11/25/2009 | CN100562319C 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof |
| 11/24/2009 | US7622482 anticancer agents; tyrosine kinase inhibitors based on pyrazole-3-amine linked through amine to fused heterocyclic ring such as benzimidazole, or imidazo[4,5-b]pyridine; e.g. N-(5-cyclopropyl-1H-pyrazol-3-yl)-3-(1-(4-fluorophenyl)ethyl)-3H-imidazo[4,5-b]pyridin-5-amine |
| 11/24/2009 | US7622474 Asulfonyl(urea, thiourea, guanidine, cyanoguanidine) compounds; cardiovascular disorders; thrombosis |
| 11/24/2009 | CA2541832C Substituted 2h-[1,2,4]triazolo[4,3-a]pyrazines as gsk-3 inhibitors |